11β-hydroxysteroid dehydrogenase types 1 and 2:: An important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids

被引:121
作者
Diederich, S
Eigendorff, E
Burkhardt, P
Quinkler, M
Bumke-Vogt, C
Rochel, M
Seidelmann, D
Esperling, P
Oelkers, W
Bähr, V
机构
[1] Free Univ Berlin, Klinikum Benjamin Franklin, Dept Endocrinol Diabetol & Nutr, D-12200 Berlin, Germany
[2] Schering AG, Res Labs, D-12200 Berlin, Germany
关键词
D O I
10.1210/jc.2002-020970
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The 11beta-hydroxysteroid dehydrogenase (11beta-HSD) system plays a pivotal role in glucocorticoid (GC) and mineralocorticoid (MC) action. Although 11beta-HSD activities are important determinants for the efficacy of synthetic MCs and GCs, corresponding pharmacokinetic data are scanty. Therefore, we characterized 11beta-HSD profiles for a wide range of steroids often used in clinical practice. 11beta-HSD1 and 11beta-HSD2 were selectively examined in 1) human liver and kidney cortex microsomes, and 2) Chinese hamster ovarian cells stably transfected with 11beta-HSDI or 11beta-HSD2 expression vectors. Both systems produced concordant evidence for the following conclusions. Oxidation of steroids by 11beta-HSD2 is diminished if they are fluorinated in position 6alpha or 9alpha (e.g. in dexamethasone) or methylated at 2alpha or 6alpha (in methylprednisolone) or 16alpha or 16beta, by a methylene group at 16 (in prednylidene), methyloxazoline at 16, 17 (in deflazacort), or a 2-chlor configuration. Whereas the methyl groups also decrease reductase activity (steric effects), fluorination increases reductase activity (negative inductive effect), leading to a shift to reductase activity. This may explain the strong MC activity of 9alpha-fluorocortisol and should be considered in GC therapy directed to 11beta-HSD2-expressing tissues (kidney, colon, and placentofetal unit). 11beta-HSD2 oxidation of prednisolone is more effective than that of cortisol, explaining the reduced MC activity of prednisolone compared with cortisol. Reduction by 11beta-HSD1 is diminished by 16alpha-methyl, 16beta-methyl, 2alpha-methyl, and 2-chlor substitution, whereas it is increased by the Delta(1)-dehydro configuration in prednisone, resulting in higher hepatic first pass activation of prednisone compared with cortisone. To characterize a GC or a MC as substrate for the different 11betaHSDs may be essential for an optimized steroid therapy.
引用
收藏
页码:5695 / 5701
页数:7
相关论文
共 33 条
[21]   11β-hydroxysteroid dehydrogenase type 1 from human liver:: Dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase [J].
Maser, E ;
Völker, B ;
Friebertshäuser, J .
BIOCHEMISTRY, 2002, 41 (07) :2459-2465
[22]  
OELKERS W, 1994, J CLIN ENDOCR METAB, V78, P9628
[23]   Progesterone metabolism in the human kidney and inhibition of 11β-hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites [J].
Quinkler, M ;
Johanssen, S ;
Grossmann, C ;
Bähr, V ;
Müller, M ;
Oelkers, W ;
Diederich, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :4165-4171
[24]   Clinical implications of glucocorticoid metabolism by 11β-hydroxysteroid dehydrogenases in target tissues [J].
Quinkler, M ;
Oelkers, W ;
Diederich, S .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 144 (02) :87-97
[25]   Immunohistochemical localization of type 1 11β-hydroxysteroid dehydrogenase in human tissues [J].
Ricketts, ML ;
Verhaeg, JM ;
Bujalska, I ;
Howie, AJ ;
Rainey, WE ;
Stewart, PM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (04) :1325-1335
[26]   IMMUNOHISTOLOGICAL OBSERVATIONS IN RAT-KIDNEY ALLOGRAFTS AFTER LOCAL STEROID-ADMINISTRATION [J].
RUERS, TJM ;
BUURMAN, WA ;
VANBOXTEL, CJ ;
VANDERLINDEN, CJ ;
KOOTSTRA, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) :1205-1220
[27]   LOCAL TREATMENT OF RENAL-ALLOGRAFTS, A PROMISING WAY TO REDUCE THE DOSAGE OF IMMUNOSUPPRESSIVE DRUGS - COMPARISON OF VARIOUS WAYS OF ADMINISTERING PREDNISOLONE [J].
RUERS, TJM ;
BUURMAN, WA ;
SMITS, JFM ;
VANDERLINDEN, CJ ;
VANDONGEN, JJ ;
STRUYKERBOUDIER, HAJ ;
KOOTSTRA, G .
TRANSPLANTATION, 1986, 41 (02) :156-161
[28]   Localization of 11 beta-hydroxysteroid dehydrogenase type II in human epithelial tissues [J].
Smith, RE ;
Maguire, JA ;
SteinOakley, AN ;
Sasano, H ;
Takahashi, KI ;
Fukushima, K ;
Krozowski, ZS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3244-3248
[29]   Cortisol metabolism in human obesity:: Impaired cortisone→cortisol conversion in subjects with central adiposity [J].
Stewart, PM ;
Boulton, A ;
Kumar, S ;
Clark, PMS ;
Shackleton, CHL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (03) :1022-1027
[30]   11β-hydroxysteroid dehydrogenase type 2 in human lung:: Possible regulator of mineralocorticoid action [J].
Suzuki, T ;
Sasano, H ;
Suzuki, S ;
Hirasawa, G ;
Takeyama, J ;
Muramatsu, Y ;
Date, F ;
Nagura, H ;
Krozowski, ZS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11) :4022-4025